NASDAQ: ALECAlector Inc Stock Ownership - Who owns Alector?
Insider buying vs selling
Have Alector Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Arnon Rosenthal | Chief Executive Officer | 2024-03-04 | 18,837 | $6.92 | $130.39kSell |
| Marc Grasso | Chief Financial Officer | 2024-03-04 | 5,716 | $6.92 | $39.56kSell |
| Gary Romano | Chief Medical Officer | 2024-03-04 | 6,001 | $6.93 | $41.56kSell |
| Sara Kenkaremitra | President and Head of RD | 2024-03-04 | 10,169 | $6.92 | $70.39kSell |
| Arnon Rosenthal | Chief Executive Officer | 2023-12-04 | 23,831 | $5.56 | $132.50kSell |
| Gary Romano | Chief Medical Officer | 2023-12-04 | 5,035 | $5.56 | $27.99kSell |
| Marc Grasso | Chief Financial Officer | 2023-12-04 | 4,574 | $5.56 | $25.43kSell |
| Sara Kenkaremitra | President and Head of RD | 2023-12-04 | 12,519 | $5.56 | $69.61kSell |
| Polaris Venture Management Co Vi LLC | 10% Owner | 2023-09-11 | 500,000 | $6.00 | $3.00MSell |
| Terrance McGuire | Director | 2023-09-11 | 500,000 | $6.00 | $3.00MSell |
ALEC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ALEC insiders and whales buy or sell their stock.
ALEC Shareholders
What type of owners hold Alector Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Polaris Venture Management Co Vi LLC | 24.76% | 23,712,011 | $120.69M | Insider |
| Terrance McGuire | 13.53% | 12,952,589 | $65.93M | Insider |
| Fmr LLC | 13.18% | 12,620,404 | $64.24M | Institution |
| Blackrock Inc | 8.43% | 8,068,553 | $41.07M | Institution |
| Morgan Stanley | 4.86% | 4,650,191 | $23.67M | Institution |
| Vanguard Group Inc | 4.58% | 4,386,541 | $22.33M | Institution |
| Ecor1 Capital LLC | 4.24% | 4,056,548 | $20.65M | Institution |
| Braidwell LP | 3.47% | 3,324,308 | $16.92M | Institution |
| State Street Corp | 3.26% | 3,117,529 | $15.87M | Institution |
| Arnon Rosenthal | 2.77% | 2,652,880 | $13.50M | Insider |
ALEC vs Biotech Stocks
Alector Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.